- WHATS NEW?
- Suppression of chemokines by HDL
- HDL cholesterol linked to oestrogen levels
- New gene loci regulating HDL cholesterol identified
- Abnormal lipids when young predicts atherosclerosis in later life
- JUPITER: Is HDL cholesterol relevant to residual risk in low-risk patients on potent statin therapy?
- EAS Workshop: How does HDL protect against atherosclerosis?
Combination nicotinic acid/laropiprant: effective with reduced flushing
Extended release (ER) nicotinic acid plus laropiprant, a PGD2 antagonist, provided effective overall lipid control with significantly less flushing than reported with ER nicotinic acid alone.
Corporate sponsor
